DIMERIX LTD

0.240

-0.010-4.00%

Volume:765.45K

Turnover:192.36K

Market Cap:144.10M

PE:-4.83

High:0.275

Open:0.250

Low:0.240

Close:0.250

52wk High:0.665

52wk Low:0.157

Shares:600.40M

Float Shares:467.70M

Volume Ratio:0.76

T/O Rate:0.16%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.050

EPS(LYR):-0.050

ROE:-594.54%

ROA:-29.36%

PB:-9.76

PE(LYR):-4.83

Loading ...

Overview Company News Filings

Dimerix Poised to Benefit From US FDA's Approval of Travere Therapeutics' Kidney Disorder Drug, Euroz Hartleys Says

MT Newswires Live

·

Apr 14

Dimerix Sees No Impact From US Pharma Tariffs, Says Euroz Hartleys

MT Newswires Live

·

Apr 08

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/DXB.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"DXB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DXB.AU\",,,,,undefined,":{"symbol":"DXB.AU","market":"AU","secType":"STK","nameCN":"DIMERIX LTD","latestPrice":0.24,"timestamp":1789366320000,"preClose":0.25,"halted":0,"volume":765446,"delay":0,"changeRate":-0.040000000000000036,"nameEN":"DIMERIX LTD","floatShares":467696880,"shares":600396776,"eps":-0.0497,"marketStatus":"Closed","change":-0.01,"latestTime":"09-14 16:12:00 AEST","open":0.25,"high":0.275,"low":0.24,"amount":192363,"amplitude":0.14,"askPrice":0.25,"askSize":72150,"bidPrice":0.24,"bidSize":79523,"shortable":3,"etf":0,"ttmEps":-0.0497,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789430400000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.25,"openAndCloseTimeList":[[1789344000000,1789365600000]],"volumeRatio":0.758785,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"DXB.AU","preClose":0.25,"auctionPrice":0.24,"auctionVolume":17360,"auctionTime":1789366198289,"referencePrice":0.24,"referenceTime":1789381803089,"auction":3,"marketStatus":"盘后竞价","timestamp":1789366198289}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DXB.AU\",,,,,undefined,":{"symbol":"DXB.AU","floatShares":467696880,"roa":"-29.36%","roe":"-594.54%","lyrEps":-0.0497,"volumeRatio":0.758785,"shares":600396776,"dividePrice":0,"high":0.275,"amplitude":0.14,"preClose":0.25,"low":0.24,"week52Low":0.157,"pbRate":"-9.76","psRate":"22.68","week52High":0.665,"institutionHeld":0,"latestPrice":0.24,"committee":0.048611,"eps":-0.0497,"divideRate":0,"volume":765446,"delay":0,"ttmEps":-0.0497,"open":0.25,"prevYearClose":0.55,"prevWeekClose":0.25,"prevMonthClose":0.28,"prevQuarterClose":0.205,"fiveDayClose":0.28,"twentyDayClose":0.3,"sixtyDayClose":0.22,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DXB.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DXB.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DXB.AU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2627999814","title":"Dimerix Poised to Benefit From US FDA's Approval of Travere Therapeutics' Kidney Disorder Drug, Euroz Hartleys Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2627999814","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627999814?lang=en_us&edition=fundamental","pubTime":"2026-04-14 12:01","pubTimestamp":1776139286,"startTime":"0","endTime":"0","summary":"Dimerix (ASX:DXB) is poised to benefit from the US Food and Drug Administration's recent approval of Travere Therapeutics' sparsentan drug to treat focal segmental glomerulosclerosis, a rare kidney di","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4139","BK4539","DXB.AU","BK7501","BK7067","LENZ","BK4588","BK7508","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625399752","title":"Dimerix Sees No Impact From US Pharma Tariffs, Says Euroz Hartleys","url":"https://stock-news.laohu8.com/highlight/detail?id=2625399752","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625399752?lang=en_us&edition=fundamental","pubTime":"2026-04-08 13:55","pubTimestamp":1775627705,"startTime":"0","endTime":"0","summary":"Dimerix  is protected from recent US pharmaceutical tariff changes due to its out-licensing model, Euroz Hartleys said in a note on Tuesday.The Trump administration imposed tariffs on imported patented pharmaceuticals under Section 232 of the Trade Expansion Act, citing national security risks in the pharmaceutical supply chain.The standard tariffs are 100%, with reduced rates of 15% for the European Union, Japan, South Korea, Switzerland, and Liechtenstein, and 10% for the United Kingdom. The administration is allowing a transition period of 120 days for large companies and 180 days for small companies before these tariffs take effect.Euroz Hartleys notes that the company's out-licensing model shields it from higher manufacturing costs, with royalties and milestone payments tied to revenue rather than production expenses, meaning the US tariffs are not expected to affect the company's financial forecasts.Euroz Hartleys maintained its speculative buy rating on Dimerix with a price targ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7501","DXB.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":42,"code":"91000000","status":"200"}]}}